Vedolizumab May Offer Hope for People with Colitis or Crohn’s Disease

One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.

Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.

The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.

During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.

Our Blogs

Bloating – Listen to What Your Gut is Telling You

Many people live with bloating, stomach discomfort, acid reflux, or irregular digestion for so long that they start thinking it’s "normal." But hey, just because it’s common doesn’t mean it should be ignored. Your digestive system plays a big role in how you feel...

Bloating. Fatigue. Discomfort. It’s Not Normal – It’s a Signal

🩺 Your gut is controlling more of your health than you think. Frequent bloating, ongoing fatigue, abdominal discomfort, acid reflux, or changes in your digestion are not issues you should simply "live with." These symptoms are often your body’s way of signaling that...

Bloating Every Day Is Not Normal

Feeling bloated after every meal? Constant heartburn or stomach discomfort shouldn't be something you just "live with." Your digestive system plays a huge role in your overall health, and ignoring symptoms can delay proper care. ✨ The earlier you address digestive...